COMMUNIQUÉS West-GlobeNewswire

Syapse Launches Precision Medicine Council to Advance Health System Adoption of Precision Oncology
07/06/2018
A group of the nation’s leading health systems will share best practices and strategies to accelerate precision medicine SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- Syapse, the leading precision medicine company, [...]
Photocure ASA: Mandatory notification of trade
07/06/2018
Jan H. Egberts, Chairperson of the Board of Photocure ASA and primary insider in Photocure ASA, has on 7 June 2018 purchased 12,500 shares in Photocure ASA at a price of NOK 27.6687 per share. Following the transaction [...]
Recording of the First Quarter 2018 Investor Conference Webinar
07/06/2018
Recording of the First Quarter 2018 Investor Conference Webinar On June 7 AS „Olainfarm” organized its Investor Conference Online Webinar. During the webinar the member of the management board of AS „Olainfarm” Salvis [...]
Navamedic ASA: Annual General Meeting held
07/06/2018
Navamedic ASA has today, 7 June 2018, held an annual general meeting. All resolutions were made in accordance with the board's/nomination committee's proposals. The minutes from the general meeting is attached hereto [...]
NYMOX Successfully Achieves Manufacturing Scale-Up
07/06/2018
HASBROUCK HEIGHTS, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that manufacturing scale-up milestones have been reached for the Company's lead compound [...]
BIOMODEX Raises an Additional $15M in Series A Funding
07/06/2018
Latest investment from Idinvest Partners and InnovAllianz to support technological development and enable the opening a manufacturing facility in Massachusetts Boston, June 07, 2018 (GLOBE NEWSWIRE) -- BIOMODEX , a [...]
Maury Jayson, MD to Offer Minimally Invasive HIFU Treatment to Men with Localized Prostate Cancer in South Florida
07/06/2018
HIFU, or high intensity focused ultrasound, is a non-invasive, outpatient, radiation-free treatment for prostate cancer CHARLOTTE, N.C., June 07, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC (HPS), the leading [...]
MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase
07/06/2018
Study achieved primary endpoint of safety and tolerability Progressive dosing of Treprostinil Technosphere (TreT) significantly exceeded the corresponding peak plasma and exposure levels of the maximum recommended dose [...]
Olainfarm holds First Quarter 2018 Investor Conference Webinar
07/06/2018
Olainfarm holds First Quarter 2018 Investor Conference Webinar AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on June [...]
CohBar Announces the Appointment of Dr. Philippe Calais to its Board
07/06/2018
MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related [...]
Radius Health to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
07/06/2018
WALTHAM, Mass., June 07, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that Jesper Høiland, President and Chief Executive Officer and Pepe Carmona, Senior Vice President and Chief Financial [...]
Sarepta Therapeutics Appoints Gilmore O’Neill, M.B., M.M.Sc. as Chief Medical Officer
07/06/2018
-- Dr. O’Neill joins Sarepta from Biogen, where he served as senior vice president of late-stage clinical development, including Spinraza® for spinal muscular atrophy (SMA); brings deep clinical experience in neurology [...]
K2M Surpasses 100th Product Milestone with FDA Clearance and Launch of OZARK™ Cervical Plate Systems
07/06/2018
Achievement highlights K2M’s broad impact on treating spinal disease LEESBURG, Va., June 07, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex spine and [...]
Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association
07/06/2018
NEWTOWN, Pa., June 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]
Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131
07/06/2018
MADISON, Wis., June 07, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments [...]
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
07/06/2018
Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) HACKENSACK, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), a leader in the [...]
Iovance Biotherapeutics Announces First Patient Dosed in Europe for Ongoing C-144-01 Phase 2 Trials in Metastatic Melanoma
07/06/2018
SAN CARLOS, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor infiltrating lymphocyte (TIL) technology [...]
Alder BioPharmaceuticals® Names Robert W. Azelby President and Chief Executive Officer
07/06/2018
Former executive at Juno Therapeutics and Amgen, Azelby brings deep operational and commercialization expertise BOTHELL, Wash., June 07, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) a [...]
Insmed to Present at Three June Conferences
07/06/2018
BRIDGEWATER, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that management will [...]

Pages